Category: Biotechnology
Global Biotechnology
-
Exosome Research Products
... at a CAGR of 20.6% over the analysis period 2024-2030. Kits & Reagents, one of the segments analyzed in the report, is expected to record a 22.2% CAGR and reach US$697.8 Million by the end ... Read More
-
Tissue Engineering
... CAGR of 12.5% over the analysis period 2024-2030. Orthopedics, Musculoskeletal & Spine, one of the segments analyzed in the report, is expected to record a 10.2% CAGR and reach US$12.7 Billion by the end of ... Read More
-
Wound Care Biologics
... at a CAGR of 9.8% over the analysis period 2024-2030. Biologic Skin Substitutes, one of the segments analyzed in the report, is expected to record a 10.4% CAGR and reach US$3.1 Billion by the end ... Read More
-
Lactase
... 5.3% over the analysis period 2024-2030. Yeast, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$235.9 Million by the end of the analysis period. Growth in ... Read More
-
Bone Cement and Glue
... 2030, growing at a CAGR of 5.0% over the analysis period 2024-2030. Bone Cement, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach US$1.1 Billion by the ... Read More
-
Burn Care
... CAGR of 3.9% over the analysis period 2024-2030. Advanced Burn Care, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$1.5 Billion by the end of the ... Read More
-
Combination Antibody Therapy
... at a CAGR of 14.0% over the analysis period 2024-2030. Chemotherapy / Antibody Therapy, one of the segments analyzed in the report, is expected to record a 9.8% CAGR and reach US$169.7 Billion by the ... Read More
-
Apoptosis
... 4.6% over the analysis period 2024-2030. Assay Kits, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.9 Billion by the end of the analysis period. Growth ... Read More
-
3D Cell Culture
... at a CAGR of 13.9% over the analysis period 2024-2030. Scaffold-based, one of the segments analyzed in the report, is expected to record a 14.0% CAGR and reach US$1.7 Billion by the end of the ... Read More
-
High Throughput Process Development
... 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Monoclonal Antibodies, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$17.8 Billion by the ... Read More
-
Real-time PCR (qPCR) and Digital PCR (dPCR)
... expected to reach US$8.4 Billion by 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Quantitative, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. DNA & RNA Sample Preparation Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR ... Read More
-
Genotyping
... 15.3% over the analysis period 2024-2030. Polymerase Chain Reaction (PCR) Technology, one of the segments analyzed in the report, is expected to record a 15.9% CAGR and reach US$10.9 Billion by the end of the ... Read More
-
Human Identification
... CAGR of 7.7% over the analysis period 2024-2030. Reagents & Consumables, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$2.0 Billion by the end of the ... Read More
-
Human Microbiome
... CAGR of 28.4% over the analysis period 2024-2030. Gastrointestinal Diseases, one of the segments analyzed in the report, is expected to record a 28.6% CAGR and reach US$1.3 Billion by the end of the analysis ... Read More
-
Hydrophobic Interaction Chromatography
... at a CAGR of 6.3% over the analysis period 2024-2030. Resins, one of the segments analyzed in the report, is expected to record a 7.3% CAGR and reach US$263.1 Million by the end of the ... Read More
-
Bovine-Based Collagen for Biomedical Applications
... Billion by 2030, growing at a CAGR of 6.8% over the analysis period 2024-2030. Bone Graft Substitutes, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$526.9 ... Read More
-
Cord Blood Banking Services
... 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Private, one of the segments analyzed in the report, is expected to record a 10.6% CAGR and reach US$79.3 Billion by the end ... Read More
-
Transfection Reagents and Equipment
... 2030, growing at a CAGR of 6.1% over the analysis period 2024-2030. Reagents, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.2 Billion by the end ... Read More
-
Electron Microscopy and Sample Preparation
... Billion by 2030, growing at a CAGR of 8.3% over the analysis period 2024-2030. Industrial End-Use, one of the segments analyzed in the report, is expected to record a 9.0% CAGR and reach US$3.2 Billion ... Read More
-
Optical Emission Spectroscopy (OES)
... 2030, growing at a CAGR of 5.2% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$718.1 Million by the end ... Read More
-
Orthobiologics
... 4.2% over the analysis period 2024-2030. Viscosupplementation, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in ... Read More
-
Single-Use Bioreactors
... CAGR of 15.1% over the analysis period 2024-2030. Single-Use Bioreactor Systems, one of the segments analyzed in the report, is expected to record a 17.1% CAGR and reach US$6.1 Billion by the end of the ... Read More
-
Sample Preparation
... CAGR of 4.6% over the analysis period 2024-2030. Consumables, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$4.5 Billion by the end of the analysis period. ... Read More
-
Terahertz Technology
... CAGR of 28.8% over the analysis period 2024-2030. Terahertz Source, one of the segments analyzed in the report, is expected to record a 29.1% CAGR and reach US$1.8 Billion by the end of the analysis ... Read More
Research Assistance
